Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver-kidney transplant recipients

Yazawa, M; Cseprekal, O; Helmick, RA; Talwar, M; Balaraman, V; Podila, PSB; Fossey, S; Satapathy, SK; Eason, JD; Molnar, MZ

Molnar, MZ (corresponding author), Univ Tennessee, Methodist Transplant Epidemiol Res Grp, James D Eason Transplant Inst, Hlth Sci Ctr,Methodist Univ Hosp, 1211 Union Ave, Memphis, TN 38104 USA.

RENAL FAILURE, 2020; 42 (1): 40


Background: De novo Donor Specific Antibodies (DSA) are considered as a risk factor for the kidney allograft outcomes in recipients after simultaneous......

Download PDF

Full Text Link